Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Drug Free Solution Inc.
Fiscal year is June-May. All values USD millions. 2011 2012 2013 5-year trend
Sales/Revenue - - 0 0 0
Cost of Goods Sold (COGS) incl. D&A - - 0 0 972
COGS excluding D&A - - 0 0 0
Depreciation & Amortization Expense - - 0 0 972
Depreciation - - 0 0 972
Amortization of Intangibles - - 0 0 0
Gross Income - - 0 0 (972)
2011 2012 2013 5-year trend
SG&A Expense - - 429 29,559 754,896
Research & Development - - 0 0 0
Other SG&A - - 429 29,559 754,896
Other Operating Expense - - 0 0 0
Unusual Expense - - 0 0 0
EBIT after Unusual Expense - - 0 0 0
Non Operating Income/Expense - - 0 0 0
Non-Operating Interest Income - - - - 0
Equity in Affiliates (Pretax) - - - 0 0
Interest Expense - - 0 376 0
Gross Interest Expense - - 0 376 0
Interest Capitalized - - 0 0 0
Pretax Income - - (429) (29,935) (755,868)
Income Tax - - 0 0 0
Income Tax - Current Domestic - - 0 0 -
Income Tax - Current Foreign - - 0 0 -
Income Tax - Deferred Domestic - - 0 0 -
Income Tax - Deferred Foreign - - 0 0 -
Income Tax Credits - - 0 0 -
Equity in Affiliates - - 0 0 0
Other After Tax Income (Expense) - - 0 0 0
Consolidated Net Income - - (429) (29,935) (755,868)
Minority Interest Expense - - 0 0 0
Net Income - - (429) (29,935) (755,868)
Extraordinaries & Discontinued Operations - - 0 0 0
Extra Items & Gain/Loss Sale Of Assets - - - 0 0
Cumulative Effect - Accounting Chg - - - - 0
Discontinued Operations - - 0 0 0
Net Income After Extraordinaries - - (429) (29,935) (755,868)
Preferred Dividends - - 0 0 0
Net Income Available to Common - - (429) (29,935) (755,868)
EPS (Basic) - - 0.00 () (0.01)
Basic Shares Outstanding - - 8.1M 9.45M 71.74M
EPS (Diluted) - - 0.00 () (0.01)
Diluted Shares Outstanding - - 8.1M 9.45M 71.74M
EBITDA - - (429) (29,559) (754,896)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.